0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > Hemagglutinin 1 (HA1)

Hemagglutinin 1 (HA1)

Brief Information

Name:Minor Histocompatibility Protein HA-1
Target Synonym:Rho GTPase Activating Protein 45,HLA-HA1,HA-1,Histocompatibility (Minor) HA-1,HMHA1,Minor Histocompatibility Antigen HA-1,KIAA0223,ARHGAP45
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
HA1-V52H5 Influenza Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin 1 (HA1) Protein, His Tag (MALS verified)
HA1-V52H5-structure
HA1-V52H5-sds
ACRO Quality

Part of Bioactivity data

HA1-V52H5-MALS-HPLC
Hemagglutinin 1 (HA1) MALS images

The purity of Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] HA1 Protein, His Tag (Cat. No. HA1-V52H5) is more than 90% and the molecular weight of this protein is around 170-190 kDa verified by SEC-MALS.

HA1-V52H5-ELISA
 Hemagglutinin 1 (HA1) ELISA

Immobilized Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin 1 (HA1) Protein, His Tag (Cat. No. HA1-V52H5) at 1 μg/mL (100 μL/well) can bind Anti-HA Monoclonal Antibody (H9N2) with a linear range of 0.1-4 ng/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TSC-100 TSC-100 Phase 1 Clinical TScan Therapeutics Inc Hematologic Neoplasms; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details
TSC-100 TSC-100 Phase 1 Clinical TScan Therapeutics Inc Hematologic Neoplasms; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

totop

Nachricht schicken